EUDA Health Holdings Limited (EUDA) Financial Ratios
6 years of historical data (2020–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: 204.13
P/B Ratio
N/A
—
5yr avg: 150.35
30Y Low150.4·High150.4
ROE
N/A
—
5yr avg: 611.8%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
EUDA Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
EUDA Health Holdings Limited currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $29M | $86M | $145M | $33M | $20M | $90M | — |
| Enterprise Value | $31M | $88M | $146M | $36M | $23M | $90M | — |
| P/E Ratio → | -10.60 | — | — | — | — | 104.28 | — |
| P/S Ratio | 4.31 | 12.58 | 36.17 | 8.84 | 5.26 | 19.79 | — |
| P/B Ratio | — | — | — | — | — | 150.35 | — |
| P/FCF | — | — | — | — | — | 204.13 | — |
| P/OCF | — | — | — | — | — | 203.23 | — |
P/E links to full P/E history page with 30-year chart
EUDA EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 12.89 | 36.43 | 9.69 | 6.21 | 19.85 | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | 84.13 | — |
| EV / FCF | — | — | — | — | — | 204.75 | — |
EUDA Profitability
Margins and return-on-capital ratios measuring operating efficiency
EUDA Health Holdings Limited earns an operating margin of -35.8%. Operating margins have expanded from -106.9% to -35.8% over the past 3 years, signaling improving operational efficiency.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 43.9% | 43.9% | 19.0% | 22.7% | 23.1% | 27.4% | 43.8% |
| Operating Margin | -35.8% | -35.8% | -432.2% | -106.9% | -151.9% | -12.3% | -10.1% |
| Net Profit Margin | -40.7% | -40.7% | -382.9% | -270.9% | -661.1% | 19.0% | 2.0% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | 611.8% | — |
| ROA | -160.9% | -160.9% | -1010.2% | -74.5% | -148.0% | 12.5% | 3.0% |
| ROIC | — | — | — | — | -913.9% | -82.8% | -472.5% |
| ROCE | — | — | — | — | — | -238.3% | — |
EUDA Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $2M ($2M total debt minus $345145 cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 0.77 | — |
| Debt / EBITDA | — | — | — | — | — | — | — |
| Net Debt / Equity | — | — | — | — | — | 0.45 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | 0.62 | — |
| Interest Coverage | -10.92 | -10.92 | -392.00 | -362.18 | -264.57 | 8.46 | -13.58 |
EUDA Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.18x is below 1.0, meaning current liabilities exceed current assets. The current ratio has improved from 0.08x to 0.18x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.18 | 0.18 | 0.18 | 0.08 | 0.86 | 0.59 | 0.70 |
| Quick Ratio | 0.18 | 0.18 | 0.15 | 0.08 | 0.84 | 0.59 | 0.70 |
| Cash Ratio | 0.06 | 0.06 | 0.06 | 0.02 | 0.00 | 0.03 | 0.04 |
| Asset Turnover | — | 3.97 | 2.32 | 2.83 | 0.15 | 0.57 | 1.51 |
| Inventory Turnover | 1345.80 | 1345.80 | 25.19 | — | 4.47 | — | — |
| Days Sales Outstanding | — | 17.89 | 15.49 | 23.55 | 18.70 | 327.35 | 66.41 |
EUDA Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
EUDA Health Holdings Limited does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 1.0% | — |
| FCF Yield | — | — | — | — | — | 0.5% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $2M | $2M | $1M | $601483 | $462667 | $371113 |
Peer Comparison
Compare EUDA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 EUDAYou | $29M | -10.6 | — | — | 43.9% | -35.8% | — | — | — |
 ACMR | $7B | 80.2 | 54.2 | — | 44.4% | 12.1% | 6.2% | 7.0% | 2.4 |
 HIMS | $8B | 69.5 | 55.1 | 105.3 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 |
 TALK | $873M | 130.3 | 138.6 | — | 43.0% | 1.4% | 6.6% | 3.9% | — |
 OPRX | $93M | 18.4 | 5.9 | 5.0 | 63.3% | 11.0% | 4.2% | 6.8% | 1.6 |
 WELL | $145B | 148.7 | 64.6 | 50.8 | 39.2% | 3.3% | 2.5% | 0.5% | 8.6 |
 TDOC | $1B | -7.1 | 17.1 | 5.1 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 AMWL | $141M | -1.4 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — |
 DOCS | $4B | 20.9 | 16.8 | — | 89.1% | 33.3% | 19.3% | 19.8% | 0.0 |
 GDRX | $922M | 31.2 | 4.2 | 5.6 | 92.8% | 11.0% | 4.5% | 10.6% | 0.3 |
 VEEV | $25B | 28.2 | 19.7 | 18.0 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 6 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
EUDA — Frequently Asked Questions
Quick answers to the most common questions about buying EUDA stock.
What is EUDA Health Holdings Limited's P/E ratio?
EUDA Health Holdings Limited's current P/E ratio is -10.6x. The historical average is 104.3x.
Is EUDA stock overvalued?
Based on historical data, EUDA Health Holdings Limited is trading at a P/E of -10.6x. Compare with industry peers and growth rates for a complete picture.
What are EUDA Health Holdings Limited's profit margins?
EUDA Health Holdings Limited has 43.9% gross margin and -35.8% operating margin.